isoxazoles has been researched along with Atopic Hypersensitivity in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gaeta, F; Quaratino, D; Romano, A; Viola, M; Volpetti, S | 1 |
| d'Atri, G; Di Pierro, F; Leoni, F; Marcucci, F | 1 |
| Amano, Y; Kitagawa, H; Mizushima, Y; Ogata, K | 1 |
| Bartlett, RR; Jarman, ER; Kuba, A; Montermann, E; Reske-Kunz, AB | 1 |
4 other study(ies) available for isoxazoles and Atopic Hypersensitivity
| Article | Year |
|---|---|
Parecoxib tolerability in patients with hypersensitivity to nonsteroidal anti-inflammatory drugs.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Hypersensitivity, Immediate; Immune Tolerance; Isoxazoles; Male; Middle Aged | 2006 |
Use of type I and type IV hypersensitivity responses to define the immunopharmacological profile of drugs.
Topics: Animals; C-Reactive Protein; Cyclosporine; Drug Evaluation, Preclinical; Female; Hypersensitivity, Delayed; Hypersensitivity, Immediate; Immunosuppressive Agents; Indomethacin; Isoxazoles; Leflunomide; Mice; Mice, Inbred BALB C | 1997 |
Oral administration of leflunomide (HWA486) results in prominent suppression of immunoglobulin E formation in a rat type 1 allergy model.
Topics: Administration, Oral; Aniline Compounds; Animals; Antibody Specificity; Crotonates; Disease Models, Animal; Drug Administration Schedule; Female; Hydroxybutyrates; Hypersensitivity, Immediate; Immunoglobulin E; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lymphocyte Activation; Nitriles; Ovalbumin; Rats; Rats, Inbred BN; Toluidines; Uridine | 1999 |
Inhibition of murine IgE and immediate cutaneous hypersensitivity responses to ovalbumin by the immunomodulatory agent leflunomide.
Topics: Adjuvants, Immunologic; Adoptive Transfer; Allergens; Animals; Antibody Formation; Down-Regulation; Female; Hypersensitivity, Immediate; Immunoglobulin E; Immunologic Memory; Interleukin-5; Isoxazoles; Leflunomide; Mice; Mice, Inbred BALB C; Ovalbumin; Skin Diseases; T-Lymphocytes; Vaccination | 1999 |